Gene · 2621
NIH grants2,018
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,081 to 1,100 of 2,018
Download this page as JSON| Grant | Title | GAS6 papers | Newest fiscal year |
|---|---|---|---|
| R01HL126901 | PARP9 and PARP14 in atherosclerosis | 1 | 2019 |
| R01HL127173 | Macrophage SR-BI Regulates Autophagy, Angiogenin and tRNA-derived small RNAs | 1 | 2019 |
| R01HL127499 | Mechanical Regulation of Tumor Angiogenesis | 1 | 2019 |
| R01HL128457 | Signaling Pathways in Dilated Cardiomyopathy | 1 | 2019 |
| R01HL128485 | miRNA Regulation of the Mitochondrial Genome | 1 | 2019 |
| R01HL131789 | Signaling mechanisms by which mitochondria regulates fibrosis in the lung | 1 | 2019 |
| R01HL132988 | The Role of IL-6 in Experimental Post Thrombotic Syndrome | 1 | 2019 |
| R01NS087147 | Vascular Ectonucleotidase Regulation of Ischemic Stroke | 1 | 2019 |
| R01NS091620 | Precision Medicine For Pediatric Low-Grade Gliomas | 1 | 2019 |
| R15HD099588 | Genome-Wide Analysis of the Transcriptional Cooperation Between Runx2 And Runx3 During Skeletal Development | 1 | 2019 |
| R21CA216745 | Adipose stromal cell targeting: a new approach to breast cancer treatment | 1 | 2019 |
| R21CA218635 | Slow-cycling cells, therapy resistance and clinical implications in prostate cancer | 1 | 2019 |
| R21EB024889 | Engineered Airway Construct for Cystic Fibrosis Disease Modeling | 1 | 2019 |
| R21ES028957 | Endocrine Disruptors, Ahr Signaling, and Placentation | 1 | 2019 |
| R21NS111186 | Investigating the biology of human neurotoxic reactive astrocytes using induced pluripotent stem cells | 1 | 2019 |
| R35CA197529 | Targeting Tumor Suppressive Pathways for Cancer Therapy | 1 | 2019 |
| R37AI049660 | A Model System for the Study of Human B-cell Tolerance | 1 | 2019 |
| R37NS047344 | Local circuitry mechanisms regulating adult hippocampal neurogenesis | 1 | 2019 |
| R44NS097047 | Development of new anti-epilepsy treatments targeting cellular energetics through mitochondrial modulation with optimal pharmacokinetics and toxicity profiles | 1 | 2019 |
| R56AG060767 | Small Molecules as Therapeutic Targets for Alzheimer's Disease | 1 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/grants?page=55